Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23147507)

1.

A quantitative postmortem MRI design sensitive to white matter hyperintensity differences and their relationship with underlying pathology.

Murray ME, Vemuri P, Preboske GM, Murphy MC, Schweitzer KJ, Parisi JE, Jack CR Jr, Dickson DW.

J Neuropathol Exp Neurol. 2012 Dec;71(12):1113-22. doi: 10.1097/NEN.0b013e318277387e.

2.

Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.

Moll NM, Rietsch AM, Thomas S, Ransohoff AJ, Lee JC, Fox R, Chang A, Ransohoff RM, Fisher E.

Ann Neurol. 2011 Nov;70(5):764-73. doi: 10.1002/ana.22521.

3.

Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.

Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, Scheltens P, Geurts JJ.

Brain. 2008 Dec;131(Pt 12):3286-98. doi: 10.1093/brain/awn265. Epub 2008 Oct 16.

4.

Do brain T2/FLAIR white matter hyperintensities correspond to myelin loss in normal aging? A radiologic-neuropathologic correlation study.

Haller S, Kövari E, Herrmann FR, Cuvinciuc V, Tomm AM, Zulian GB, Lovblad KO, Giannakopoulos P, Bouras C.

Acta Neuropathol Commun. 2013 May 9;1(1):14. doi: 10.1186/2051-5960-1-14.

5.

Changes in normal-appearing white matter precede development of white matter lesions.

de Groot M, Verhaaren BF, de Boer R, Klein S, Hofman A, van der Lugt A, Ikram MA, Niessen WJ, Vernooij MW.

Stroke. 2013 Apr;44(4):1037-42. doi: 10.1161/STROKEAHA.112.680223. Epub 2013 Feb 21.

6.

Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.

Seewann A, Vrenken H, van der Valk P, Blezer EL, Knol DL, Castelijns JA, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ.

Arch Neurol. 2009 May;66(5):601-9. doi: 10.1001/archneurol.2009.57.

PMID:
19433660
7.

Longitudinal relaxographic imaging of white matter hyperintensities in the elderly.

Anderson VC, Obayashi JT, Kaye JA, Quinn JF, Berryhill P, Riccelli LP, Peterson D, Rooney WD.

Fluids Barriers CNS. 2014 Oct 20;11:24. doi: 10.1186/2045-8118-11-24. eCollection 2014.

8.

Diffusion tensor imaging and cognition in cerebral small vessel disease: the RUN DMC study.

van Norden AG, de Laat KF, van Dijk EJ, van Uden IW, van Oudheusden LJ, Gons RA, Norris DG, Zwiers MP, de Leeuw FE.

Biochim Biophys Acta. 2012 Mar;1822(3):401-7. doi: 10.1016/j.bbadis.2011.04.008. Epub 2011 Apr 29.

9.

White matter hyperintensities in the forties: their prevalence and topography in an epidemiological sample aged 44-48.

Wen W, Sachdev PS, Li JJ, Chen X, Anstey KJ.

Hum Brain Mapp. 2009 Apr;30(4):1155-67. doi: 10.1002/hbm.20586.

PMID:
18465744
10.

Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging.

Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, Blacker D, Albert MS, Guttmann CR, Greenberg SM.

Stroke. 2008 Apr;39(4):1127-33. doi: 10.1161/STROKEAHA.107.497438. Epub 2008 Feb 21.

11.

FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins.

Sati P, George IC, Shea CD, Gaitán MI, Reich DS.

Radiology. 2012 Dec;265(3):926-32. doi: 10.1148/radiol.12120208. Epub 2012 Oct 16.

12.

Functional impact of white matter hyperintensities in cognitively normal elderly subjects.

Murray ME, Senjem ML, Petersen RC, Hollman JH, Preboske GM, Weigand SD, Knopman DS, Ferman TJ, Dickson DW, Jack CR Jr.

Arch Neurol. 2010 Nov;67(11):1379-85. doi: 10.1001/archneurol.2010.280.

13.

A fully automated method for quantifying and localizing white matter hyperintensities on MR images.

Wu M, Rosano C, Butters M, Whyte E, Nable M, Crooks R, Meltzer CC, Reynolds CF 3rd, Aizenstein HJ.

Psychiatry Res. 2006 Dec 1;148(2-3):133-42. Epub 2006 Nov 13.

14.

Neuropathologic correlates of white matter hyperintensities.

Young VG, Halliday GM, Kril JJ.

Neurology. 2008 Sep 9;71(11):804-11. doi: 10.1212/01.wnl.0000319691.50117.54. Epub 2008 Aug 6.

PMID:
18685136
15.

Reduced retention of Pittsburgh compound B in white matter lesions.

Glodzik L, Rusinek H, Li J, Zhou C, Tsui W, Mosconi L, Li Y, Osorio R, Williams S, Randall C, Spector N, McHugh P, Murray J, Pirraglia E, Vallabhajolusa S, de Leon M.

Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):97-102. doi: 10.1007/s00259-014-2897-1. Epub 2014 Oct 21.

PMID:
25331458
16.

Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease.

Targosz-Gajniak M, Siuda J, Ochudło S, Opala G.

J Neurol Sci. 2009 Aug 15;283(1-2):79-82. doi: 10.1016/j.jns.2009.02.314. Epub 2009 Mar 6.

PMID:
19268974
17.

Characterization of white matter degeneration in elderly subjects by magnetic resonance diffusion and FLAIR imaging correlation.

Zhan W, Zhang Y, Mueller SG, Lorenzen P, Hadjidemetriou S, Schuff N, Weiner MW.

Neuroimage. 2009 Aug;47 Suppl 2:T58-65. doi: 10.1016/j.neuroimage.2009.02.004. Epub 2009 Feb 20.

18.

A quantitative study of white matter hypomyelination and oligodendroglial maturation in focal cortical dysplasia type II.

Shepherd C, Liu J, Goc J, Martinian L, Jacques TS, Sisodiya SM, Thom M.

Epilepsia. 2013 May;54(5):898-908. doi: 10.1111/epi.12143. Epub 2013 Mar 28.

19.

FLAIR and diffusion MRI signals are independent predictors of white matter hyperintensities.

Maillard P, Carmichael O, Harvey D, Fletcher E, Reed B, Mungas D, DeCarli C.

AJNR Am J Neuroradiol. 2013 Jan;34(1):54-61. doi: 10.3174/ajnr.A3146. Epub 2012 Jun 14.

20.

Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.

Zhang Y, Moore GR, Laule C, Bjarnason TA, Kozlowski P, Traboulsee A, Li DK.

Ann Neurol. 2013 Jul;74(1):91-9. doi: 10.1002/ana.23867. Epub 2013 Aug 12.

PMID:
23939554
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk